2025-08-19 - Analysis Report
Okay, here's an analysis of Colgate-Palmolive Co (CL) based on the provided data, presented in a structured and informative manner.

## Colgate-Palmolive Co (CL) Stock Analysis

**Company Overview:** Colgate-Palmolive Co (CL) is a global consumer products company focused on the production, distribution, and provision of household, health care, personal care, and veterinary products.

### 1. Performance vs. S&P 500 (VOO)

**Key Metrics:**

*   **CL Cumulative Return:** 11.82%
*   **VOO Cumulative Return:** 100.85%
*   **Absolute Deviation:** -74.1% (CL underperformed VOO)
*   **Deviation Range (Max, Min):** (8.5, -75.2)
*   **Relative Deviation:** 1.3%

**Analysis:**

CL has significantly underperformed the S&P 500 (VOO) over the analyzed period. The -74.1% deviation indicates a substantial difference in cumulative returns.  The Relative Deviation of 1.3% suggests that the current underperformance is near the lowest end of its historical range compared to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 13.0% | 4.5% | -16.0% | 0.0 | 61.0 |
| 2016-2018  | -11.0% | 65.2% | -29.0% | 0.1 | 48.1 |
| 2017-2019  | 7.0% | 65.2% | -22.0% | 0.1 | 55.6 |
| 2018-2020  | 18.0% | 65.2% | -2.0% | 0.6 | 69.1 |
| 2019-2021  | 30.0% | 58.6% | -19.0% | 0.7 | 69.0 |
| 2020-2022  | 7.0% | 69.0% | 5.0% | 0.7 | 63.7 |
| 2021-2023  | 6.0% | 69.0% | -12.0% | 0.8 | 64.4 |
| 2022-2024  | 13.0% | 69.0% | -12.0% | 0.8 | 73.5 |
| 2023-2025  | -1.0% | 70.6% | -54.0% | 0.3 | 68.1 |

**Analysis:**

*   **Alpha:** Consistently negative alpha values indicate that CL has generally underperformed its benchmark after adjusting for risk.  The most recent period (2023-2025) shows a particularly large negative alpha.
*   **Beta:**  Beta values are generally low, suggesting CL is less volatile than the overall market. In recent years, the beta has been slightly increasing.
*   **CAGR:** The Compound Annual Growth Rate (CAGR) varies. The most recent period shows negative CAGR.
*   **MDD:** The Maximum Drawdown (MDD)  fluctuates.
*   **Cap(B):** Market capitalization is in Billions.

### 2. Recent Price Action

*   **Current Price:** $84.26
*   **Previous Close:** $85.07
*   **Change:** -0.95%
*   **5-Day Moving Average:** 85.06
*   **20-Day Moving Average:** 85.53
*   **60-Day Moving Average:** 88.68

**Analysis:**

The current price is below all three moving averages, indicating a short-term downtrend. The recent price decrease and negative change suggest some selling pressure.

### 3. Market Risk Indicators and Signals

*   **Market Risk Indicator (MRI):** 0.3285 (Low Risk)
*   **RSI:** 37.64 (Approaching Oversold)
*   **PPO:** 0.18
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (4 shares - Safe - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** 0.1 (Positive - Short-term Increase)
*   **Expected Return:** -1964.9% (Long-term underperformance relative to S&P 500)

**Analysis:**

*   **MRI:** Indicates a low-risk environment.
*   **RSI:** The RSI value suggests the stock is nearing oversold conditions, potentially signaling a possible bounce.
*   **PPO:** The PPO measures the difference between two moving averages, expressed as a percentage of the longer moving average. It helps identify potential overbought and oversold conditions and can confirm trend direction.
*   **Hybrid Signal:** The signal suggests buying a significant portion (90%) using available cash (4 shares).
*   **Recent Relative Deviation:** The slight increase in relative deviation suggests a minor short-term improvement in performance compared to the benchmark.
*   **Expected Return:**  The extremely negative expected return indicates a projected long-term underperformance compared to the S&P 500 if a buy-and-hold strategy is implemented at the current level.
*   **Recent Price Change:** The current price decrease and negative change suggest some selling pressure.

### 4. Recent News & Significant Events

*   **2025-08-16:** Major business developments, regulatory changes, or market events.
*   **2025-08-19:** Analyst discussions on recent performance and outlook considering industry and global economic factors.
*   **2025-08-18:** Notable stock volatility influenced by recent news, earnings reports, or executive actions.
*   **2025-08-17:** Market experts highlight both risks and opportunities, advising investors to monitor recent news and company announcements.

**Analysis:**

Recent news indicates potential volatility and significant developments impacting CL.  Analysts are actively discussing the company's performance, suggesting increased market attention. Investors should monitor news for potential risks and opportunities.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출     |
|--------------|------|----------|
| 2025-08-01   | 0.92 | 5.11 B$  |
| 2025-04-25   | 0.85 | 4.91 B$  |
| 2024-10-25   | 0.90 | 5.03 B$  |
| 2024-07-26   | 0.89 | 5.06 B$  |
| 2025-08-01   | 0.89 | 5.06 B$  |

**Analysis:**

*   **EPS (Earnings Per Share):**  EPS has fluctuated slightly over the recent quarters.
*   **Revenue:**  Revenue has also shown some fluctuation, but remains relatively stable around $5 billion.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-06-30   | $5.11B    | 60.06%        |
| 2025-03-31   | $4.91B    | 60.82%        |
| 2024-12-31   | $4.95B    | 60.30%        |
| 2024-09-30   | $5.03B    | 61.08%        |
| 2024-06-30   | $5.06B    | 60.62%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE       |
|--------------|-----------|-----------|
| 2025-06-30   | $0.70B    | 105.84%   |
| 2025-03-31   | $0.36B    | 190.08%   |
| 2024-12-31   | $0.21B    | 348.58%   |
| 2024-09-30   | $0.43B    | 169.43%   |
| 2024-06-30   | $0.12B    | 594.31%   |

**Analysis:**

*   **Revenue and Profit Margin:** Revenue is stable around $5 billion, and profit margins are consistently high, around 60%.
*   **Equity and ROE (Return on Equity):** Equity has fluctuated and is on the lower side. ROE is exceptionally high, which could be due to the relatively low equity.

### 7. Overall Summary

*   **Underperformance:** CL has significantly underperformed the S&P 500, with a large negative deviation in cumulative returns.
*   **Low Volatility:** The stock exhibits lower volatility than the overall market, as indicated by its low beta.
*   **Recent Downtrend:**  The current price is below key moving averages, suggesting a recent downtrend.
*   **Oversold Conditions:** The RSI indicates that the stock might be approaching oversold territory.
*   **Stable Financials:** Revenue and profit margins are stable and high, but equity is low, leading to very high ROE figures.
*   **Negative Outlook:**  The significantly negative expected return suggests a long-term underperformance compared to the S&P 500.
*   **Recent News Impact:** Recent news and analyst discussions suggest potential volatility and market attention.
*   **Hybrid Signal:** Hybrid Signal suggests buying a significant portion (90%) using available cash (4 shares).

**Conclusion:**

Based on the provided data, Colgate-Palmolive Co (CL) appears to be facing challenges, especially when compared to the broader market. While the company maintains stable revenue and high profit margins, the stock's underperformance and negative expected return warrant caution. Investors should closely monitor recent news and company announcements and consider the potential risks and opportunities before making investment decisions. The Hybrid Signal suggests a potential buying opportunity, but this should be weighed against the overall negative outlook.
